Who are Isoflurane Inhalant Product's main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): Sevoflurane, Isoflurane, Desflurane, generic sevoflurane, sevoflurane in step up concentration, Isoflurane, Sevoflurane or Desflurane, Isoflurane Volatile Liquid, Volatile anesthetic.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/isoflurane-inhalant-product.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-17 · How we verify

Isoflurane Inhalant Product — Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Isoflurane Inhalant Product (Isoflurane Inhalant Product) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Volatile inhalational anesthetic. Area: Anesthesiology.

phase 3 Volatile inhalational anesthetic GABA-A receptor, NMDA receptor Anesthesiology Small molecule Live · refreshed every 30 min

Target snapshot

Isoflurane Inhalant Product (Isoflurane Inhalant Product) — Sunnybrook Health Sciences Centre. Isoflurane is a volatile anesthetic that depresses the central nervous system by enhancing inhibitory neurotransmission and suppressing excitatory pathways, producing unconsciousness and analgesia.

Comparator set (6 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target
Isoflurane Inhalant Product TARGET	Isoflurane Inhalant Product	Sunnybrook Health Sciences Centre	phase 3	Volatile inhalational anesthetic	GABA-A receptor, NMDA receptor
Sevoflurane, Isoflurane, Desflurane	Sevoflurane, Isoflurane, Desflurane	University Hospital, Basel, Switzerland	marketed	Volatile anesthetic	GABA-A receptor, NMDA receptor
generic sevoflurane	generic sevoflurane	Asan Medical Center	marketed	Volatile halogenated ether anesthetic	GABA-A receptor, NMDA receptor
sevoflurane in step up concentration	sevoflurane in step up concentration	University Hospital, Ghent	marketed	Volatile general anesthetic	GABA-A receptor, NMDA receptor
Isoflurane, Sevoflurane or Desflurane	Isoflurane, Sevoflurane or Desflurane	King's College Hospital NHS Trust	marketed	Volatile anesthetic	GABA-A receptor, NMDA receptor
Isoflurane Volatile Liquid	Isoflurane Volatile Liquid	Federal University of São Paulo	marketed	Volatile anesthetic	GABA-A receptor, NMDA receptor
Volatile anesthetic	Volatile anesthetic	London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's	marketed	Volatile anesthetic	GABA-A receptor, NMDA receptor

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Volatile inhalational anesthetic class)

Sunnybrook Health Sciences Centre · 2 drugs in this class
Sichuan Provincial People's Hospital · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Isoflurane Inhalant Product — Competitive Intelligence Brief. https://druglandscape.com/ci/isoflurane-inhalant-product. Accessed 2026-05-17.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab